StockData
Verastem, Inc. logo

Verastem, Inc. (VSTM) stock

VSTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$7.41−0.29 (-3.77%)

Close on Nov 17, 2026Market cap $671.08MP/E –Yield –

Verastem price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Verastem's price to sales ratio was 9.4× on Nov 11, 2026, against 56.9× a year earlier. Over the last 5 years it ranged from 3.6× to 241.5×, with a median of 13.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20269.4×−48.7
2025Oct 31, 202558.1×+28.0
2023Apr 28, 202330.2×+3.4
2022Dec 30, 202226.8×−158.7
2021Dec 31, 2021185.4×+181.5
2020Dec 31, 20203.9×−2.7
2019Dec 31, 20196.6×–

More Verastem figures

See a number that looks wrong?